Literature DB >> 24740279

The effect of noggin interference in a rabbit posterolateral spinal fusion model.

E Klineberg1, D R Haudenschild, K D Snow, S Garitty, B A Christiansen, C Acharya, S Maitra, M C Gupta.   

Abstract

STUDY
DESIGN: Noggin protein levels and spinal fusion rates were compared in a rabbit model after application of siRNA against BMP antagonist noggin in paraspinal muscle.
OBJECTIVE: To test whether endogenous BMPs are sufficient to form bone in the absence of their antagonists, using noggin siRNA to interrupt the negative feedback loop on endogenous BMP within the paraspinal muscles in rabbits. Unused Posterolateral lumbar fusion is a standard surgical treatment for many spinal disorders, yet even under ideal conditions the rate of non-fusion approaches 25 %. BMPs are effective in promoting bone formation, and are inhibited by antagonists such as noggin. We have previously shown that in this model, endogenous BMPs are present and endogenous BMP antagonist noggin is strongly increased during spinal fusion. Previous studies have found that noggin siRNA enhanced spinal fusion in combination with supra-physiological amounts of exogenous BMP; however, the effect of the siRNA alone remains unknown.
METHODS: A posterolateral intertransverse rabbit lumbar fusion was utilized, as established by Boden et al. SiRNA against noggin was electroporated into paraspinal muscle to determine its effect on fusion. Outcome measures included noggin protein expression, and assessment of spinal fusion at 6 weeks.
RESULTS: SiRNAs were effective in reducing overexpressed noggin in vitro. Noggin protein was successfully knocked down in vivo for the initial 7 days in our rabbit model and returned to detectable levels by 4 weeks and to normal levels by 6 weeks. The overall fusion rate was not significantly enhanced compared to established controls from our earlier work (Tang et al.).
CONCLUSIONS: Early noggin suppression does not appear to enhance the BMP activity sufficiently to significantly affect final fusion rates in our model.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24740279     DOI: 10.1007/s00586-014-3252-8

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  34 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Function of BMPs and BMP antagonists in adult bone.

Authors:  Etsuko Abe
Journal:  Ann N Y Acad Sci       Date:  2006-04       Impact factor: 5.691

Review 3.  Current concepts of molecular aspects of bone healing.

Authors:  Rozalia Dimitriou; Eleftherios Tsiridis; Peter V Giannoudis
Journal:  Injury       Date:  2005-08-15       Impact factor: 2.586

4.  The effects of BMP-7 in a rat posterolateral intertransverse process fusion model.

Authors:  Michael L Salamon; Peter L Althausen; Munish C Gupta; Justin Laubach
Journal:  J Spinal Disord Tech       Date:  2003-02

5.  Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts.

Authors:  E Gazzerro; V Gangji; E Canalis
Journal:  J Clin Invest       Date:  1998-12-15       Impact factor: 14.808

Review 6.  Critical analysis of trends in fusion for degenerative disc disease over the past 20 years: influence of technique on fusion rate and clinical outcome.

Authors:  Christopher M Bono; Casey K Lee
Journal:  Spine (Phila Pa 1976)       Date:  2004-02-15       Impact factor: 3.468

7.  Retroviral delivery of Noggin inhibits the formation of heterotopic ossification induced by BMP-4, demineralized bone matrix, and trauma in an animal model.

Authors:  David Hannallah; Hairong Peng; Brett Young; Arvydas Usas; Brian Gearhart; Johnny Huard
Journal:  J Bone Joint Surg Am       Date:  2004-01       Impact factor: 5.284

8.  Acceleration of regenerate ossification during distraction osteogenesis with recombinant human bone morphogenetic protein-7.

Authors:  Yoshihiko Mizumoto; Timothy Moseley; Michael Drews; Virgil N Cooper; A Hari Reddi
Journal:  J Bone Joint Surg Am       Date:  2003       Impact factor: 5.284

9.  An experimental lumbar intertransverse process spinal fusion model. Radiographic, histologic, and biomechanical healing characteristics.

Authors:  S D Boden; J H Schimandle; W C Hutton
Journal:  Spine (Phila Pa 1976)       Date:  1995-02-15       Impact factor: 3.468

10.  Under-reported complications related to BMP use in spine surgery.

Authors:  Per Aspenberg
Journal:  Acta Orthop       Date:  2011-10       Impact factor: 3.717

View more
  5 in total

1.  Efficient in vitro delivery of Noggin siRNA enhances osteoblastogenesis.

Authors:  S Ghadakzadeh; R C Hamdy; M Tabrizian
Journal:  Heliyon       Date:  2017-11-13

2.  Application of Cytokines of the Bone Morphogenetic Protein (BMP) Family in Spinal Fusion - Effects on the Bone, Intervertebral Disc and Mesenchymal Stromal Cells.

Authors:  Rahel Deborah May; Daniela Angelika Frauchiger; Christoph Emmanuel Albers; Adel Tekari; Lorin Michael Benneker; Frank Michael Klenke; Willy Hofstetter; Benjamin Gantenbein
Journal:  Curr Stem Cell Res Ther       Date:  2019       Impact factor: 3.828

3.  A novel tissue-engineered bone graft composed of silicon-substituted calcium phosphate, autogenous fine particulate bone powder and BMSCs promotes posterolateral spinal fusion in rabbits.

Authors:  LiHuang Cui; ShouYang Xiang; DeChun Chen; Rui Fu; Xin Zhang; JingTao Chen; XinTao Wang
Journal:  J Orthop Translat       Date:  2020-09-14       Impact factor: 5.191

4.  Binding to COMP Reduces the BMP2 Dose for Spinal Fusion in a Rat Model.

Authors:  Motasem Refaat; Eric O Klineberg; Michael C Fong; Tanya C Garcia; J Kent Leach; Dominik R Haudenschild
Journal:  Spine (Phila Pa 1976)       Date:  2016-07-15       Impact factor: 3.241

5.  Autologous blood coagulum is a physiological carrier for BMP6 to induce new bone formation and promote posterolateral lumbar spine fusion in rabbits.

Authors:  Slobodan Vukicevic; Lovorka Grgurevic; Igor Erjavec; Marko Pecin; Tatjana Bordukalo-Niksic; Nikola Stokovic; Marija Lipar; Hrvoje Capak; Drazen Maticic; Reinhard Windhager; T Kuber Sampath; Munish Gupta
Journal:  J Tissue Eng Regen Med       Date:  2019-11-10       Impact factor: 3.963

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.